NMNAT2 is downregulated in glaucomatous RGCs, and RGC-specific gene therapy rescues neurodegeneration and visual function
Open Access
- 31 January 2022
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 30 (4), 1421-1431
- https://doi.org/10.1016/j.ymthe.2022.01.035
Abstract
No abstract availableKeywords
Funding Information
- National Eye Institute
- National Natural Science Foundation of China
This publication has 80 references indexed in Scilit:
- Deletions within its subcellular targeting domain enhance the axon protective capacity of Nmnat2 in vivoScientific Reports, 2013
- The Phr1 Ubiquitin Ligase Promotes Injury-Induced Axon Self-DestructionCell Reports, 2013
- Subcellular Localization Determines the Stability and Axon Protective Capacity of Axon Survival Factor Nmnat2PLoS Biology, 2013
- The Highwire Ubiquitin Ligase Promotes Axonal Degeneration by Tuning Levels of Nmnat ProteinPLoS Biology, 2012
- NMNAT1 mutations cause Leber congenital amaurosisNature Genetics, 2012
- Mutations in NMNAT1 cause Leber congenital amaurosis and identify a new disease pathway for retinal degenerationNature Genetics, 2012
- A biomechanical paradigm for axonal insult within the optic nerve head in aging and glaucomaExperimental Eye Research, 2011
- Endogenous Nmnat2 Is an Essential Survival Factor for Maintenance of Healthy AxonsPLoS Biology, 2010
- Cell-type-specific isolation of ribosome-associated mRNA from complex tissuesProceedings of the National Academy of Sciences of the United States of America, 2009
- Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucomaThe Journal of cell biology, 2007